相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune Checkpoint Inhibitor-Associated Polymyalgia Rheumatica/Giant Cell Arteritis Occurring in a Patient After Treatment With Nivolumab
Albrecht Edward Betrains et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2021)
Arterial lesions in giant cell arteritis: A longitudinal study
Tanaz A. Kermani et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica
Diana Prieto-Pena et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Should 18F-FDG-PET imaging be used in the diagnosis of GCA?
Dario Camellino et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications
Robert Busch et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis
Ciro Manzo et al.
RHEUMATOLOGY (2019)
Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica
Claire E. Owen et al.
RHEUMATOLOGY (2018)
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study
Zoe Paskins et al.
BMC MEDICINE (2018)
Therapeutic response to prednisone in relation to age in polymyalgia rheumatica: a comparison study
Aline Charpentier et al.
CLINICAL RHEUMATOLOGY (2018)
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC
Riemer H. J. A. Slart et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Nomenclature for factors of the HLA system, update May 2018
Steven G.E. Marsh
HUMAN IMMUNOLOGY (2018)
Comparable Rates of Glucocorticoid-Associated Adverse Events in Patients With Polymyalgia Rheumatica and Comorbidities in the General Population
Izzat Shbeeb et al.
ARTHRITIS CARE & RESEARCH (2018)
Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis
Hui Zhang et al.
CIRCULATION (2018)
A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica
Bertrand Robilliard et al.
EUROPEAN JOURNAL OF CANCER (2018)
Immune Checkpoints as Therapeutic Targets in Autoimmunity
Christopher Paluch et al.
FRONTIERS IN IMMUNOLOGY (2018)
Does low risk of infections as a marker of effective immunity predict increased risk of subsequent giant cell arteritis or polymyalgia rheumatica? A Danish population-based case-control study
Clement Brault et al.
CLINICAL EPIDEMIOLOGY (2018)
Comorbidities in polymyalgia rheumatica: a systematic review
Richard Partington et al.
ARTHRITIS RESEARCH & THERAPY (2018)
The real evidence for polymyalgia rheumatica as a paraneoplastic syndrome
S. Muller et al.
REUMATISMO (2018)
Update on treatment of polymyalgia rheumatica
D. Camellino et al.
REUMATISMO (2018)
Comorbidity in polymyalgia rheumatica
C. Chatzigeorgiou et al.
REUMATISMO (2018)
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study
Marie Kostine et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab
Anais Huwart et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
Kenneth F. Baker et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta-analysis
Lana Yin Hui Lai et al.
RMD OPEN (2018)
HLA-DRB1 the notorious gene in the mosaic of autoimmunity
Maria-Teresa Arango et al.
IMMUNOLOGIC RESEARCH (2017)
Baseline Shoulder Ultrasonography Is Not a Predictive Marker of Response to Glucocorticoids in Patients with Polymyalgia Rheumatica: A 12-month Followup Study
Maria Concetta Miceli et al.
JOURNAL OF RHEUMATOLOGY (2017)
Trial of Tocilizumab in Giant-Cell Arteritis
J. H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Epidemiology of Polymyalgia Rheumatica 2000-2014 and Examination of Incidence and Survival Trends Over 45 Years: A Population-Based Study
Shafay Raheel et al.
ARTHRITIS CARE & RESEARCH (2017)
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Lenore Buckley et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study
Maurizio Cutolo et al.
RMD OPEN (2017)
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study
M. Rossini et al.
REUMATISMO (2017)
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
L. Khoja et al.
ANNALS OF ONCOLOGY (2017)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study
Valerie Devauchelle-Pensec et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Polymyalgia Rheumatica and Giant Cell Arteritis A Systematic Review
Frank Buttgereit et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study
Gulsen Ozen et al.
JOURNAL OF RHEUMATOLOGY (2016)
Are the New ACR/EULAR Criteria the Ultimate Answer for Polymyalgia Rheumatica Classification?
Dario Camellino et al.
JOURNAL OF RHEUMATOLOGY (2016)
Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study
Maxime Sondag et al.
RHEUMATOLOGY (2016)
Brief Report: A Prospective Open-Label Phase IIa Trial of Tocilizumab in the Treatment of Polymyalgia Rheumatica
Lindsay Lally et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus
Lekh N. Dahal et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids
Sarah Louise Mackie et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica
Yogesh P. Singh et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Giant Cell Arteritis: Beyond Corticosteroids
Lauren Steel et al.
DRUGS & AGING (2015)
Association of HLA-DRB1 Haplotypes With Rheumatoid Arthritis Severity, Mortality, and Treatment Response
Sebastien Viatte et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
I suddenly felt I'd aged: A qualitative study of patient experiences of polymyalgia rheumatica (PMR)
Helen Twohig et al.
PATIENT EDUCATION AND COUNSELING (2015)
Differences in fluorodeoxyglucose positron emission tomography/computed tomography findings between elderly onset rheumatoid arthritis and polymyalgia rheumatica
Hiroyuki Takahashi et al.
MODERN RHEUMATOLOGY (2015)
Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study
M. Fallah et al.
ANNALS OF ONCOLOGY (2014)
Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype
M. Fallah et al.
ANNALS OF ONCOLOGY (2014)
Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis
Sarah Louise Mackie et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study
Pierluigi Macchioni et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
A systematic review and pooled analysis of the prevalence of rotator cuff disease with increasing age
Teun Teunis et al.
JOURNAL OF SHOULDER AND ELBOW SURGERY (2014)
Paraneoplastic syndromes in rheumatology
Bernhard Manger et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain
Dario Camellino et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of CTLA-4
Barbara L. Goldstein et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Disturbed B Cell Homeostasis in Newly Diagnosed Giant Cell Arteritis and Polymyalgia Rheumatica
Kornelis S. M. van der Geest et al.
ARTHRITIS & RHEUMATOLOGY (2014)
NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The soluble isoform of CTLA-4 as a regulator of T-cell responses
Frank J. Ward et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
MECHANISMS OF DISEASE JAKs and STATs in Immunity, Immunodeficiency, and Cancer
John J. O'Shea et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography
Marco A. Cimmino et al.
RHEUMATOLOGY (2013)
Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR)
Jung Hwa Lee et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumaticae
N. T. Baerlecken et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Bhaskar Dasgupta et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis
Maxime Samson et al.
ARTHRITIS AND RHEUMATISM (2012)
Patient-reported Outcomes in Polymyalgia Rheumatica
Eric L. Matteson et al.
JOURNAL OF RHEUMATOLOGY (2012)
Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis
Dario Camellino et al.
RHEUMATOLOGY (2012)
Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Circulating cytokines in active polymyalgia rheumatica
L. Alvarez-Rodriguez et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Altered T-cell subtypes in spondyloarthritis, rheumatoid arthritis and polymyalgia rheumatica
Christian Dejaco et al.
RHEUMATOLOGY INTERNATIONAL (2010)
Nomenclature for factors of the HLA system, 2010
S. G. E. Marsh et al.
TISSUE ANTIGENS (2010)
Clinical Relevance of Persistently Elevated Circulating Cytokines (Tumor Necrosis Factor α and Interleukin-6) in the Long-Term Followup of Patients With Giant Cell Arteritis
Ana Garcia-Martinez et al.
ARTHRITIS CARE & RESEARCH (2010)
Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial
Frederik Kreiner et al.
ARTHRITIS RESEARCH & THERAPY (2010)
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
Daniele Saverino et al.
AUTOIMMUNITY HIGHLIGHTS (2010)
The multifaceted pathogenesis of polymyalgia rheumatica/giant cell arteritis
Dario Camellino et al.
ARTHRITIS AND RHEUMATISM (2009)
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury
Rita Simone et al.
INTERNATIONAL IMMUNOLOGY (2009)
Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica
PierLuigi Macchioni et al.
RHEUMATOLOGY (2009)
Serum interleukin-6 receptor in polymyalgia rheumatica: A potential marker of relapse/recurrence risk
Lia Pulsatelli et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Is FDG-PET useful in the evaluation of steroid-resistant PMR patients
M. A. Cimmino et al.
RHEUMATOLOGY (2008)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States
Reva C. Lawrence et al.
ARTHRITIS AND RHEUMATISM (2008)
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica - A randomized trial
Carlo Salvarani et al.
ANNALS OF INTERNAL MEDICINE (2007)
Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients
D. Blockmans et al.
RHEUMATOLOGY (2007)
Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis:: analysis with quantitative real time polymerase chain reaction
R Alvarez-Lafuente et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis:: Influence on clinical subgroups and prognosis
VM Martínez-Taboda et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2004)
Prednisone plus methotrexate for polymyalgia rheumatica - A randomized, double-blind, placebo-controlled trial
R Caporali et al.
ANNALS OF INTERNAL MEDICINE (2004)
A disease activity score for polymyalgia rheumatica
BF Leeb et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study
R Caporali et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: A prospective follow-up study
F Cantini et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2000)
The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatics and temporal arteritis: a prospective study of 231 cases
JT Gran et al.
RHEUMATOLOGY (2000)
分享论文
